{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T04:19:55Z","timestamp":1765772395603,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.clinthera.2020.02.014","type":"journal-article","created":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T07:06:50Z","timestamp":1586070410000},"page":"649-660.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial"],"prefix":"10.1016","volume":"42","author":[{"given":"Chongjian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.02.014_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4244\/EIJ-D-17-00557","article-title":"State of the art: coronary artery stents\u2014past, present and future","volume":"13","author":"Stefanini","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.02.014_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.02.014_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2013.12.036","volume":"63","author":"Taniwaki","year":"2014","journal-title":"JACC"},{"key":"10.1016\/j.clinthera.2020.02.014_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/17434440.2017.1378091","article-title":"Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives","volume":"14","author":"Iglesias","year":"2017","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.clinthera.2020.02.014_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2020.02.014_bib6","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.02.014_bib7","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.02.014_bib8","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very\u00a0thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised,\u00a0non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.02.014_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003610","article-title":"Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention: the SORT OUT VII Trial","volume":"9","author":"Jensen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2020.02.014_bib10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(18)32001-4","volume":"392","author":"von Birgelen","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.02.014_bib11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4244\/EIJY15M03_08","article-title":"Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry","volume":"11","author":"Waltenberger","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.02.014_bib12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4244\/EIJ-D-16-00179","article-title":"Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial","volume":"12","author":"Kang","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.02.014_bib13","first-page":"PI16","article-title":"Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease","volume":"8","author":"Kalnins","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clinthera.2020.02.014_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00058566","article-title":"Improvement of stenting therapy with a silicon carbide coated tantalum stent","volume":"7","author":"Amon","year":"1996","journal-title":"J\u00a0Mater Sci Mater Med"},{"key":"10.1016\/j.clinthera.2020.02.014_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4244\/EIJV4I4A85","volume":"4","author":"Dahm","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.02.014_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.02.014_bib17","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.02.014_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2020.02.014_bib19","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.02.014_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4244\/EIJV9I1A12","article-title":"A\u00a0randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial","volume":"9","author":"Gao","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.02.014_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1745-6215-14-398","article-title":"Angiographic and clinical comparison of novel Orsiro hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial","volume":"14","author":"Lee","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.clinthera.2020.02.014_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MCA.0000000000000470","article-title":"Angiographic and clinical outcomes after recanalization of coronary chronic total occlusions with the Orsiro sirolimus-eluting stent compared with the Resolute zotarolimus-eluting stent","volume":"28","author":"Markovic","year":"2017","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.clinthera.2020.02.014_bib23","first-page":"2561","article-title":"Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial","volume":"127","author":"Yuan","year":"2014","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.clinthera.2020.02.014_bib24","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.4244\/EIJ-D-18-01214","article-title":"BIOFLOW IV, a randomized, intercontinental, multicenter study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months","volume":"15","author":"Saito","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.02.014_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.amjcard.2013.10.042","article-title":"One-year outcomes from an all-comers Chinese population of patients implanted with the resolute zotarolimus-eluting stent","volume":"113","author":"Qiao","year":"2014","journal-title":"Am J Cardiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820301168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820301168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:51:55Z","timestamp":1758963115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291820301168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0149291820301168"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.02.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}